Codis
PrivateLast Round
Growth Equity
Oct 16, 2025
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Codis operates in Healthcare & Life Sciences and is based in St. Louis, Missouri. Its latest recorded funding round was a Growth Equity round in October 2025.
Codis is a contract development and manufacturing organization company that provides advanced solutions for the pharmaceutical and consumer health industries, specializing in spray drying and particle engineering.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Codis Comparables
Compare Codis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serán Bioscience | 86% | |
| Bend Bioscience | 82% | |
| CritiTech | 80% |
For institutional investors. Book with your work email.
Codis Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Codis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Research Corporation Technologies | Growth Equity |
| BroadOak Capital Partners | Growth Equity |
| 1315 Capital | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Open roles increased to 19, 36% of headcount.
- Aug 24, 2026
Open roles increased to 15, 2.1x the trailing average.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 21, 2026
Codis appoints Steven Facer as chief commercial officer in a newly created role overseeing Sales, Marketing and Business Development across its US and UK operations.
- promotesSep 21, 2026
Codis promotes Steven Facer to the newly created Chief Commercial Officer role on Sep 21st '26, where he leads Sales, Marketing, and Business Development to strengthen global commercial alignment.
For institutional investors. Book with your work email.
Codis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Codis's valuation, stock price, and market status.
Is Codis a public or private company?
Codis is a private company.
What is the current stock price of Codis?
Codis is a private company, so its shares have no public market price. Caplight tracks Codis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Codis worth (valuation)?
Valuation information for Codis is not publicly available.
Can I buy Codis stock?
Codis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Codis's last funding round?
Codis's most recent funding round was Growth Equity on October 16, 2025.
Who are the main investors in Codis?
Key investors in Codis include 1315 Capital.
Will Codis IPO soon?
No public IPO plans have been announced for Codis.
How can I track Codis secondary market activity?
Caplight tracks bids, offers, and trades in Codis's shares on secondary markets.